Brief: Novocure Q3 Revenue USD 155.095 Million Vs. IBES Estimate USD 143.9 Million
30/10/2024 11:00
Oct 30 (Reuters) - Novocure Q3 gross profit USD 119.723 million. * Q3 operating income USD -32.092 million vs. IBES estimate USD -42.8 million * Q3 pretax profit USD -21.585 million vs. IBES estimate USD -34.6 million * Q3 net income USD -30.57 million vs. IBES estimate USD -37.6 million
Recent news on NovoCure
See all newsOncology firm Novocure says cyberattack exposed US patient records
Novocure Ltd reports results for the quarter ended June 30 - Earnings Summary
Novocure Q2 revenue beats, lifts 2026 outlook
Brief: Novocure Q2 Revenue USD 183.584 Million Vs. IBES Estimate USD 172.4 Million
U.S. STOCKS ON THE MOVE-Kardigan, Energy companies, Take-Two, Accenture